NMVZX
Price
$13.63
Change
-$0.15 (-1.09%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

NMVZX vs VMVAX

Header iconNMVZX vs VMVAX Comparison
Open Charts NMVZX vs VMVAXBanner chart's image
Nuance Mid Cap Value Z
Price$13.63
Change-$0.15 (-1.09%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
NMVZX vs VMVAX Comparison Chart
Loading...
VS
NMVZX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMVZX is a StrongBuy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. NMVZX (1.66B). VMVAX pays higher dividends than NMVZX: VMVAX (2.14) vs NMVZX (1.77). NMVZX was incepted earlier than VMVAX: NMVZX (7 years) vs VMVAX (13 years). NMVZX is a more actively managed with annual turnover of: 62.00 vs. VMVAX (22.00). NMVZX has a lower initial minimum investment than VMVAX: NMVZX (2500) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. NMVZX (20.74). VMVAX return over 5 years is better than : 48.82 vs. NMVZX (8.41).
NMVZXVMVAXNMVZX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years13 years-
Gain YTD9.45214.94663%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets1.66B30.5B5%
Annual Yield % from dividends1.772.1483%
Returns for 1 year20.7425.3582%
Returns for 3 years-6.3920.71-31%
Returns for 5 years8.4148.8217%
Returns for 10 yearsN/A100.88-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio